| For: | Nagy F, Molnár T, Szepes Z, Farkas K, Nyári T, Lonovics J. Efficacy of 6-mercaptopurine treatment after azathioprine hypersensitivity in inflammatory bowel disease. World J Gastroenterol 2008; 14(27): 4342-4346 [PMID: 18666323 DOI: 10.3748/wjg.14.4342] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v14/i27/4342.htm |
| Number | Citing Articles |
| 1 |
|
| 2 |
Jaimin Amin, Brian Huang, Jessica Yoon, David Q. Shih. Update 2014. Inflammatory Bowel Diseases 2015; 21(2) doi: 10.1097/MIB.0000000000000197
|
| 3 |
Sarah Healy, Kariem Tarik Elhadd, Emily Gibbons, Dan Whittam, Michael Griffiths, Anu Jacob, Saif Huda. Treatment of myelin oligodendrocyte glycoprotein immunoglobulin G–associated disease. Clinical and Experimental Neuroimmunology 2021; 12(1) doi: 10.1111/cen3.12630
|
| 4 |
Jihye Park, Jae Hee Cheon. Updates on conventional therapies for inflammatory bowel diseases: 5-aminosalicylates, corticosteroids, immunomodulators, and anti-TNF-α. The Korean Journal of Internal Medicine 2022; 37(5) doi: 10.3904/kjim.2022.132
|
| 5 |
Arthur Turow, Tuck Y Yong, Jie Shen Fok, Jordan YZ Li. Azathioprine Hypersensitivity Presenting as Cardiogenic Shock and Sweet's Syndrome in a Patient with Microscopic Polyangiitis. Internal Medicine 2012; 51(14) doi: 10.2169/internalmedicine.51.6962
|
| 6 |
A. Dignass, G. Van Assche, J.O. Lindsay, M. Lémann, J. Söderholm, J.F. Colombel, S. Danese, A. D'Hoore, M. Gassull, F. Gomollón, D.W. Hommes, P. Michetti, C. O'Morain, T. Öresland, A. Windsor, E.F. Stange, S.P.L. Travis. The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: Current management. Journal of Crohn's and Colitis 2010; 4(1) doi: 10.1016/j.crohns.2009.12.002
|
| 7 |
Byong Duk Ye, Suk-Kyun Yang, Sung Jae Shin, Kang Moon Lee, Byung Ik Jang, Jae Hee Cheon, Chang Hwan Choi, Young-Ho Kim, Heeyoung Lee. Guidelines for the Management of Crohn's Disease. The Korean Journal of Gastroenterology 2012; 59(2) doi: 10.4166/kjg.2012.59.2.141
|
| 8 |
Adi Lahat, Rami Eliakim. Crohn's Disease and Ulcerative Colitis. 2017; doi: 10.1007/978-3-319-33703-6_30
|
| 9 |
Robin J. Dart, Peter M. Irving. Optimising use of thiopurines in inflammatory bowel disease. Expert Review of Clinical Immunology 2017; 13(9) doi: 10.1080/1744666X.2017.1351298
|
| 10 |
Somnath Mookherjee, Maya Narayanan, Tomoharu Uchiyama, Kelly L. Wentworth. Three Hospital Admissions in 9 Days to Diagnose Azathioprine Hypersensitivity in a Patient With Crohn's Disease. American Journal of Therapeutics 2015; 22(2) doi: 10.1097/MJT.0b013e318296f153
|
| 11 |
Byong Duk Ye, Suk-Kyun Yang, Sung Jae Shin, Kang Moon Lee, Byung Ik Jang, Jae Hee Cheon, Chang Hwan Choi, Young-Ho Kim, Heeyoung Lee. Guidelines for the Management of Crohn's Disease. Intestinal Research 2012; 10(1) doi: 10.5217/ir.2012.10.1.26
|
| 12 |
Bipadabhanjan Mallick, Sarthak Malik. Use of Azathioprine in Ulcerative Colitis: A Comprehensive Review. Cureus 2022; doi: 10.7759/cureus.24874
|
| 13 |
J.K. Aronson. A worldwide yearly survey of new data in adverse drug reactions. Side Effects of Drugs Annual 2011; 33 doi: 10.1016/B978-0-444-53741-6.00038-6
|
| 14 |
Mauro Pagani. The Complex Clinical Picture of Presumably Allergic Side Effects to Cytostatic Drugs: Symptoms, Pathomechanism, Reexposure, and Desensitization. Medical Clinics of North America 2010; 94(4) doi: 10.1016/j.mcna.2010.03.002
|
| 15 |
Motoaki Kuriyama, Jun Kato, Hideyuki Suzuki, Mitsuhiro Akita, Sakiko Hiraoka, Hiroyuki Okada, Kazuhide Yamamoto. TOLERABILITY AND USEFULNESS OF MERCAPTOPURINE IN AZATHIOPRINE‐INTOLERANT JAPANESE PATIENTS WITH ULCERATIVE COLITIS. Digestive Endoscopy 2010; 22(4) doi: 10.1111/j.1443-1661.2010.01009.x
|
| 16 |
Sherry Yang, Chauncey McHargue. An asymptomatic papulopustular eruption in an immunosuppressed patient. International Journal of Dermatology 2014; 53(11) doi: 10.1111/ijd.12653
|
| 17 |
Huma Hameed, Khurram Rehman, Anam Hameed, Abdul Qayuum. Preparation and characterization of pH-responsive ionic crosslinked microparticles of mercaptopurine to target ulcerative colitis. Polymers and Polymer Composites 2021; 29(9_suppl) doi: 10.1177/09673911211047338
|
| 18 |
Rishi M. Goel, Paul Blaker, Alex Mentzer, Steven C.M. Fong, Anthony M. Marinaki, Jeremy D. Sanderson. Optimizing the use of thiopurines in inflammatory bowel disease. Therapeutic Advances in Chronic Disease 2015; 6(3) doi: 10.1177/2040622315579063
|
| 19 |
N. A. Kennedy, E. Rhatigan, I. D. R. Arnott, C. L. Noble, A. G. Shand, J. Satsangi, C. W. Lees. A trial of mercaptopurine is a safe strategy in patients with inflammatory bowel disease intolerant to azathioprine: an observational study, systematic review and meta‐analysis. Alimentary Pharmacology & Therapeutics 2013; 38(10) doi: 10.1111/apt.12511
|